Deadline: 15 April 2025
The World Scleroderma Foundation (WSF) is pleased to announce the launch of a Major Grant and invites researchers worldwide to submit their projects for consideration.
This grant aims to support significant research initiatives in the field.
Objective
- The Major Grant is designed to fund projects focused on translational perspectives on lung fibrosis, including the pathogenesis of ILD, the mechanisms of progression, the prediction of response to treatment, the biomarkers of ILD and the outcome measures of ILD.
Funding Information
- The total available funding is €300,000, awarded to two projects (€150,000 each). Funds must be utilized within three years.
- Recipients will be contacted by the WSF Central Office to sign an agreement outlining project milestones and payment details.
- The Principal Investigator must present the final or preliminary results at the opening ceremony of the World Congress on Systemic Sclerosis in 2026.
Eligibility Criteria
- The Principal Investigator must hold a position at an academic institution or a hospital devoted to SSc care for the duration of the project.
- The applicant must demonstrate access to the necessary infrastructure to conduct the proposed research.
Ineligibility Criteria
- Institutions or individuals who have received a WSF grant in 2023 or 2024 are not eligible to apply.
- Selected applicants must sign and return the funding agreement by the deadline communicated by the WSF office.
- It should be noted that this is a condition for funding and all applicants that will not comply with the deadline will be excluded.
For more information, visit WSF.
